Clarkson Alumna Dr. Amy Jenkins Creating Antibody Therapeutic to Combat COVID-19
June 04, 2020
June 04, 2020
POTSDAM, New York, June 4 -- Clarkson University issued the following news:
Clarkson University Alumna Dr. Amy Jenkins ('02) is working on an antibody therapeutic that acts as a "temporary vaccine" to prevent infection in individuals exposed to COVID-19. The innovative therapy would essentially create an immunity that lasts for several months, making it a great tool for frontline responders during the pandemic.
Jenkins leads the Defense Advanced Research Proje . . .
Clarkson University Alumna Dr. Amy Jenkins ('02) is working on an antibody therapeutic that acts as a "temporary vaccine" to prevent infection in individuals exposed to COVID-19. The innovative therapy would essentially create an immunity that lasts for several months, making it a great tool for frontline responders during the pandemic.
Jenkins leads the Defense Advanced Research Proje . . .